In the relentless pursuit of novel therapeutics, drug discovery relies on a foundation of well-characterized and reliably sourced chemical components. NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to this field by providing intermediates of exceptional scientific merit, such as (R)-2-Methylbut-3-Enoic Acid (CAS No. 20626-49-7).

The scientific value of (R)-2-Methylbut-3-Enoic Acid lies in its precise chemical structure and high purity (>98%), making it an indispensable tool for medicinal chemists. Its specific stereochemistry and functional groups are vital for constructing complex molecular architectures found in cutting-edge pharmaceuticals. As an intermediate for Milvexian, a Factor XIa inhibitor aimed at treating thrombotic conditions, this compound directly supports the development of new treatments with significant scientific backing.

NINGBO INNO PHARMCHEM CO.,LTD.'s commitment to quality, evidenced by GMP, ISO 9001, and FDA certifications, ensures that the scientific integrity of research utilizing (R)-2-Methylbut-3-Enoic Acid is maintained. This dedication allows researchers to focus on discovery and development, confident in the reliability of their starting materials. The compound's role extends beyond specific drug synthesis; it serves as a valuable chemical entity for exploring new reaction pathways and understanding structure-activity relationships.

The scientific merit of (R)-2-Methylbut-3-Enoic Acid makes it a cornerstone for companies engaged in the demanding process of modern drug discovery. By providing this critical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. empowers the scientific community to push the boundaries of what's possible in pharmaceutical innovation.